BRCA1-associated protein-1 (BAP1) mutations
Clinical trials for BRCA1-associated protein-1 (BAP1) mutations explained in plain language.
Never miss a new study
Get alerted when new BRCA1-associated protein-1 (BAP1) mutations trials appear
Sign up with your email to follow new studies for BRCA1-associated protein-1 (BAP1) mutations, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancer: oral pill targets early mesothelioma in High-Risk patients
Disease control Recruiting nowThis study tests an oral medication (decitabine/cedazuridine) in people with BAP1 gene mutations who have early-stage mesothelioma that is not yet causing symptoms. The goal is to see if the drug can stop the cancer from growing or shrink it. About 9 participants will receive tre…
Matched conditions: BRCA1-ASSOCIATED PROTEIN-1 (BAP1) MUTATIONS
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New study aims to catch mesothelioma early in High-Risk families
Knowledge-focused Recruiting nowThis study follows 300 adults aged 30 and older who have or may have a BAP1 gene mutation, which raises the risk for mesothelioma and other cancers. Researchers will use advanced CT scans, blood tests, and minimally invasive camera procedures to look for early signs of cancer. Pa…
Matched conditions: BRCA1-ASSOCIATED PROTEIN-1 (BAP1) MUTATIONS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC